Benefits and Disadvantages of Electronic Patient-reported Outcome Measures: Systematic Review
JMIR Perioperative Medicine · 2020-04-03 · 3 (1) · e15588
DOI: 10.2196/15588 ↗At a glance
Übersichtsarbeit in JMIR Perioperative Medicine, published online on 2020-04-03. Written by Jill Meirte and 6 co-authors. Institution: Department of Rehabilitation Science and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium. Cited 300 times so far (Crossref); 53 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Patient-reported outcome measures (PROMs) are important in clinical practice and research. The growth of electronic health technologies provides unprecedented opportunities to systematically collect information via PROMs.
Objective
The aim of this study was to provide an objective and comprehensive overview of the benefits, barriers, and disadvantages of the digital collection of qualitative electronic patient-reported outcome measures (ePROMs).
Methods
We performed a systematic review of articles retrieved from PubMED and Web of Science. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed during all stages. The search strategy yielded a total of 2333 records, from which 32 met the predefined inclusion and exclusion criteria. The relevant ePROM-related information was extracted from each study.
Results
Results were clustered as benefits and disadvantages. Reported benefits of ePROMs were greater patient preference and acceptability, lower costs, similar or faster completion time, higher data quality and response rates, and facilitated symptom management and patient-clinician communication. Tablets were the most used ePROM modality (14/32, 44%), and, as a platform, Web-based systems were used the most (26/32, 81%). Potential disadvantages of ePROMs include privacy protection, a possible large initial financial investment, and exclusion of certain populations or the “digital divide.” Conclusions In conclusion, ePROMs offer many advantages over paper-based collection of patient-reported outcomes. Overall, ePROMs are preferred over paper-based methods, improve data quality, result in similar or faster completion time, decrease costs, and facilitate clinical decision making and symptom management. Disadvantages regarding ePROMs have been outlined, and suggestions are provided to overcome the barriers. We provide a path forward for researchers and clinicians interested in implementing ePROMs. Trial Registration PROSPERO CRD42018094795; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=94795
Subjects
Author keywords
Authors and institutions
- Department of Rehabilitation Science and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
- Department of Rehabilitation Sciences and Physiotherapy (REVAKI-MOVANT), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
ORCID profiles: Jill Meirte, Nick Hellemans, Mieke Anthonissen, Lenie Denteneer, Koen Maertens, Peter Moortgat, Ulrike Van Daele
Cite
APA
Meirte, J., Hellemans, N., Anthonissen, M., Denteneer, L., Maertens, K., Moortgat, P., & Van Daele, U. (2020). Benefits and Disadvantages of Electronic Patient-reported Outcome Measures: Systematic Review. JMIR Perioperative Medicine, 3(1), e15588. https://doi.org/10.2196/15588
Vancouver
Meirte J, Hellemans N, Anthonissen M, Denteneer L, Maertens K, Moortgat P, et al. Benefits and Disadvantages of Electronic Patient-reported Outcome Measures: Systematic Review. JMIR Perioperative Medicine. 2020;3(1):e15588. doi:10.2196/15588
BibTeX
@article{Meirte2020,
author = {Meirte, Jill and Hellemans, Nick and Anthonissen, Mieke and Denteneer, Lenie and Maertens, Koen and Moortgat, Peter and Van Daele, Ulrike},
title = {Benefits and Disadvantages of Electronic Patient-reported Outcome Measures: Systematic Review},
journal = {JMIR Perioperative Medicine},
year = {2020},
volume = {3},
number = {1},
pages = {e15588},
doi = {10.2196/15588}
}
EUVIMED